- Home
- MHH vs PYXS Comparison
MHH vs PYXS Comparison
Compare MHH & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHH | PYXS |
|---|---|---|
| Founded | 1986 | 2018 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.7M | 71.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MHH | PYXS |
|---|---|---|
| Price | $6.84 | $1.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 13.4K | ★ 548.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.20 | $0.83 |
| 52 Week High | $14.04 | $5.55 |
Technical Indicators
Market Signals| Indicator | MHH | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 40.02 | 35.20 |
| Support Level | $6.82 | $1.28 |
| Resistance Level | $7.09 | $1.39 |
| Average True Range (ATR) | 0.21 | 0.12 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 1.82 | 11.91 |
Price Performance
Historical ComparisonAbout MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.